MPM Focus Area

Antibody agents for the
treatment of cancer

Related Investment: CoStim


MPM Investment Strategy

MPM Capital works with leading scientists to create companies that seek to address unmet needs and change the face of medicine across all therapeutic areas. MPM is currently investing out of BV2014, its most recent venture fund. In 2015 MPM partnered with UBS to create the UBS Oncology Impact Fund (OIF), an innovative impact investing fund focused exclusively on oncology that will invest in both private and public equities. OIF will support both basic cancer research as well as access to cancer care in developing countries.



Exit Type

Focus Area

MPM Team

MPM's Team is comprised of innovators, entrepreneurs, executives & investors



Contact Us

Cambridge, MA

450 Kendall Street
Cambridge, MA 02142

Phone | 617-425-9200

see full map / get directions

San Francisco, CA

601 Gateway Boulevard
Suite 350
South San Francisco, CA 94080

Phone | 650-553-3300

see full map / get directions
Terms Of Use & Disclosures
  1. 2018
  2. 2017
  3. 2016
  4. 2015
  5. 2014